Summary of worldwide pediatric malignancies reported after exposure to etanercept

BACKGROUND: Concerns have been raised about a potential link between the use of TNF inhibitors and development of malignancy in the pediatric population. We examined the worldwide experience of etanercept use in pediatric patients and the occurrence of malignancies as reported from clinical trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: McCroskery, Peter, Wallace, Carol A, Lovell, Daniel J, Stryker, Scott, Chernyukhin, Nataliya, Blosch, Consuelo, Zack, Debra J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904755/
https://www.ncbi.nlm.nih.gov/pubmed/20546618
http://dx.doi.org/10.1186/1546-0096-8-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904755/
https://www.ncbi.nlm.nih.gov/pubmed/20546618
http://dx.doi.org/10.1186/1546-0096-8-18

Ejemplares similares